Why We Need You
Despite receiving appropriate treatment, thirty percent of those diagnosed with early stage breast cancer will eventually develop Stage 4-Metastatic Breast Cancer(MBC) and die. Once diagnosed with MBC, most have a median life expectancy of just 33 months. In the US alone, over 40,000 women die from this disease every year. If you know a woman who died of breast cancer, Stage 4-Metastatic Breast Cancer is what took her life. Yet of all the money dedicated to breast cancer research, less than 10% is earmarked specifically for metastatic research. METAvivor’s goal is to see MBC transition from a terminal diagnosis to that of a chronic disease with a normal life expectancy. This will only happen if we increase funding for metastatic research.